FRAILTY AMONG THE BENEFICIARIES OF BATUMI ST. CATHERINE NURSING HOME

Abstract

Frailty is defined as “medical syndrome with multiple causes and contributors that is characterized by diminished strength, endurance, and reduced physiologic function that increases an individual’s vulnerability for developing increased dependency and/or death. An assessment of Frailty in various populations, especially in the elderly population, has medical outcomes. The present work deals with the study of frailty in the beneficiaries of Batumi St. Catherine Nursing Home of. In total 70 beneficiaries of both sexes, were over 60 years of age, were investigated. Frailty phenotypes were assessed within five criteria: weight loss, self-reported exhaustion, weakness, slowness, and low physical activity (8). The existence of three and more criteria from these listed criteria are assessed as frail phenotype; the existence of one or two criteria - prefrail, and if a person does not have any criteria, it is assessed as robust. 25.7% of the elder beneficiaries turned out to be frailty phenotype, 12,9% - prefrail phenotype, 61.4% - healthy or sustainable. Total frailty phenotype was identified in 18 samples, including 11 women and 7 men. Hard cognitive disorders from the 18 frailty phenotypes were found in only 3 individuals. Among the three most commonly researched populations in the frailty criteria are low physical activity, weakness, and slowness. In the group of people older than 80 years, the syndrome of frailty was higher (35.7%) than in the group of people older than 60 years. (19%). The gender difference was not observed.

Keywords

• Frailty,nursing home,beneficiaries,elderly

References

1. [1] Wagner KH., Cameron-Smith D., Wessner B., Franzke B., “Biomarkers of Aging: From Function to Molecular Biology”. Nutrients. 8(6), pp. 338, 2016. doi: 10.3390/nu8060338. [2] Xia X., Chen W., Dermott J. Mc., Jing-Dong Jackie Hana, “Molecular and phenotypic biomarkers of aging”, REVIEW F1000Res.), 6, 860, 2017.
2. [3] Crimmins E., Vasunilashorn S., Kim JK, Alley D. “Biomarkers related to aging in human populations”, Adv. Clin Chem., 46, 161-216, 2008.
3. [4] Hammadah M., Al Mheid I., Wilmot K., et al.: “Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes”, Circ Res,. 120(7), 1130-1138, 2017. doi: 10.1161/CIRCRESAHA. 116.309421
4. [5] Khukhunaishvili R., Koridze M. et al.- “Some Bio-gerontological Peculiarities of Long-livers in Ajara Region of Georgia”, 19th IAGG word congress of Gerontology and Geriatrics, Paris, France. The Journal of Nutrition, Helth and Aging. 13, 2009.
5. [6] Lang P.-O., Michel J.-P., Zekry D. “Frailty Syndrome: A Transitional State in a Dynamic Process”, Gerontology, 55(5), 539–549, 2009.
6. [7] Fried LP., Tangen CM., Walston J., Newman AB., Hirsch C., Gottdiener J., et al. "Frailty in older adults: evidence for a phenotype", J Gerontol A BiolSci Med Sci, 56 (3), 146–56, 2001.
7. [8] Rockwood K., Song X., Mitnitski A. “Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey”, CMAJ, 183(8), 487–494, 2011.
8. [9] Santos-Eggimann B., Cuenoud P., Spagnoli J., Junod J. "Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries", J Gerontol A Biol Sci Med Sci 64(6), 675–681, 2009.

9. [10] Morley JE., Malmstrom TK., Miller DK. "A simple frailty questionnaire (FRAIL) Predicts outcomes in middle-aged africanamericans”, J Nutr Health Aging 16(7), 601–608, 2012.
10. [11] Strandberg TE., Pitkala KH., Tilvis RS. “Frailty in older people”, Eur Geriatr Med. 2(6), 344–355, 2011.
11. [12] DreyM., Pfeifer K., SieberC.C., Bauer J.M. “The Fried Frailty Criteria as Inclusion Criteria for a Randomized Controlled Trial: Personal Experience and Literature Review”, Gerontology 57(1), 11–18, 2011.
12. [13] Gill TM., Gahbauer EA., Allore HG., Han L. “Transitions between frailty states among community-living older persons”, Archives of Internal Medicine, 166(4), 418–423, 2006.
13. [14] Fried LP., Tangen CM., Walston J., Newman AB., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop WJ., Burke G., McBurnie MA. “Cardiovascular Health Study Collaborative Research G. Frailty in older adults: evidence for a phenotype”, J Gerontol A BiolSci Med Sci, 56(3), 146–156, 2001.
14. [15] Duarte N., Teixeira L., Ribeiro O. Paúl C. “Frailty phenotype criteria in centenarians: Findings from the Oporto”, Centenarian Study, 5(6), 371-376, 2014. DOI: 10.1016/j.eurger.2014.09.015
15. [16] Folstein MF., Folstein SE., McHugh PR: “Mini-mental state: A practical method for grading the cognitive state of patients for the clinician”, J Psychiatr Res, 12, 189-198, 1975.
16. [17] Fillenbaum GG., Smyer MA. “The development, validity, and reliability of the Oars Multidimensional Functional Assessment Questionnaire”, Journals of Gerontology, 36(4), 428–434, 1981.
17. [18] Santos-Eggimann B., Cuenoud P., Spagnoli J., Junod J. "Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries", J Gerontol A BiolSci Med Sci, 64(6), 675–81, 2009.